This article explores refined lymph node staging via bronchoscopy, indicating improved lung cancer management.
The TNM staging system is the cornerstone of lung cancer classification, providing a framework for prognosis and treatment planning in a universal nomenclature. The 9th edition of the TNM classification, released by the International Association for the Study of Lung Cancer (IASLC) and went into effect in January 2025, introduces refinements to lymph node (N) staging. Lymph node staging is performed minimally invasively using bronchoscopy with endobronchial ultrasound (EBUS). This article explores the latest updates on lymph node staging by EBUS and their implications for lung cancer management from the perspective of bronchoscopy.
No takes yet. Share an insight, caveat, or question.
Brock et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: